1Ho KK,Anderson KM,Kannel WB.Survival after the onset of congestive heart failure in Framingham Heart Study Subjects[J].Circulation,1993,88(1):107-115. 被引量：1
4Koenig W.Inflammation and coronary heart disease:an overview[J].Cardiol Rev,2001,9(1):31-35. 被引量：1
5Vitale C,Cerquetani E,Wajngarten M,et al.In patients with coronary artery disease endothelial function is associated with plasma levels of C-reactive protein and is improved by optimal medical therapy[J].Ital Heart J,2003,4(9):627-632. 被引量：1
6Ikeda U,Takahashi M,Shimada K.C-reactive protein directly inhibits nitric oxide production by cytokine-stimulated vascular smooth muscle cells[J].J Cardiovasc Pharmaco,2003,42(5):607-611. 被引量：1
7Venugopal SK,Devaraj S,Jialal I.C-reactive protein decreases prostacyclin release from human aortic endothelial cells[J].Circulation,2003,108(14):1676-1678. 被引量：1
1Jianhui Zhu, Quyyumi AA, Norman JE, et al, Effects of total pathogen burden on coronary artery disease risk and C - reactive protein levels[J] .Am J Cardiol,2000,85 : 140 - 146. 被引量：1
2Wolf MG,Zasmeta G, Homykewycz S, et al. Plasma levels of C - reactive prorein after coronary stent implantation[J] .Eur Heart J,2000,21:1152 - 1158. 被引量：1
3Lenine B, Kalman J, Mayer L, et al. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure[J]. N Eng J Med, 1990,323:236- 241. 被引量：1
4Gabay C, Kushner I. Actue - phase proteins and other systemic responses to inflammation[J]. N Eng Med, 1999,340:448 - 454. 被引量：1
5Tataru MC,Heinrich J,Junker R,et al.C - reactive protein and the severity of atherosclerosis in myocardial infarction patients with stable angina pectoris[J]. Eur Heart J,2000,21 : 1000. 被引量：1
6Albert MA, Staggers J, Chew P, et al. Investigators. The pravastatin inflammation CRP evaluation ( PRINCE ) : rationale and design [ J ]. Am Heart J,2001,141(6) :893 - 898. 被引量：1
7Ridker PM, Rifai N, Clearfield M, et ,ak. Measurement - C - reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events[ J], N Engl J Med, 2001,344(26) : 1959 - 1965. 被引量：1
8Bustos C, Hemandez- Presa MA, Ortego M, et al. HMG- COA reductase inhibition by atorvastatin reduces neointial inflammation in a rabbit model of atherosclerosis[J] .J AM Coll Cardiol, 1998,32(7) :2057 - 2064. 被引量：1
7Young YX,Jabbour S,Golderg R,et al.Usefulness of starlin drougs in protecting against areal fidrilation in patients with coronary artery disease[J].Am J Cardiol,2003,92:1379-1383. 被引量：1
8Kaput NK.Romvastatin:a higIIly potent statin for the prevention and marmgemdlt ofeormary artery disease[J].Expert Rev Cardiovasc Ther,2007,5(2):161-175. 被引量：1
